ReWalk Robotics Ltd. (RWLK)

Market Cap	56.44M
Revenue (ttm)	4.57M
Net Income (ttm)	-18.11M
Shares Out	62.79M
EPS (ttm)	-0.26
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	159,448
Open	0.9
Previous Close	0.91
Day's Range	0.889 - 0.94
52-Week Range	0.785 - 1.398
Beta	2.38
Analysts	Buy
Price Target	3.06 (+241.9%)
Earnings Date	Nov 7, 2022

About RWLK

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation envir...

• Industry: Health Care Equipment & Supplies
• IPO Date: Sep 12, 2014
• CEO: Lawrence Jasinski
• Employees: 51
• Stock Exchange: NASDAQ
• Ticker Symbol: RWLK

Financial Performance

In 2021, RWLK's revenue was $5.97 million, an increase of 35.81% compared to the previous year's $4.39 million. Losses were -$12.74 million, -1.85% less than in 2020.

Analyst Forecast

According to 7 analysts, the average rating for RWLK stock is "Buy." The 12-month stock price forecast is 3.06, which is an increase of 241.90% from the latest price.

Price Target

$3.06

(241.90% upside)

Analyst Consensus: Buy